Home » Topics » Regulatory » Patents

Patents
RSS

Glaxo Wellcome discloses cGMP-PDE inhibitors

March 24, 1997

SCRAS describes galanthamine derivatives

March 24, 1997

Pharmacia & Upjohn prepares stereoisomers of FCE-28260

March 24, 1997

Nippon Shinyaku discloses cell adhesion inhibitors

March 21, 1997

Cell migration inhibitors from Teijin

March 21, 1997

New cephalosporins from Kyoto Pharmaceutical Industries

March 21, 1997

Sagami prepares angiotensin IV agonists

March 21, 1997

Immunostimulants from Takeda

March 21, 1997

Hisamitsu claims novel antiallergic agents

March 21, 1997

PGI2 agonists described by Fujisawa

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...